Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry
![Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin | Postgraduate Medical Journal Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/94/1110/207/F1.large.jpg)
Impact of provision of time in therapeutic range value on anticoagulation management in atrial fibrillation patients on warfarin | Postgraduate Medical Journal
![CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram](https://www.researchgate.net/publication/301697757/figure/fig1/AS:357451422552064@1462234468700/CPMC-WD-therapeutic-warfarin-dosing-mg-week-and-categories-based-on-CYP2C9-VKORC1-and.png)
CPMC-WD therapeutic warfarin dosing (mg/week) and categories based on... | Download Scientific Diagram
Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis | PLOS ONE
![Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions](http://www.healthcaresystemsolutions.com/wp-content/uploads/edd/2015/02/Rosendaal_Method_Manual_Calculation_Excel_Template_Screenshot.jpg)
Excel template for Rosendaal method Time in Therapeutic Range calculations – Healthcare System Solutions
Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Trea
ASSESSMENT OF TIME IN THERAPEUTIC RANGE WITH WARFARIN THERAPY IN PHARMACIST VERSUS USUAL CARE GROUP: A RETROSPECTIVE COHORT STUD
![Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018 Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018](https://journals.sagepub.com/cms/10.1177/1076029618798944/asset/images/large/10.1177_1076029618798944-fig1.jpeg)
Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin - Clara Ting, Katelyn W. Sylvester, James W. Schurr, 2018
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry
![JCM | Free Full-Text | Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry JCM | Free Full-Text | Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry](https://www.mdpi.com/jcm/jcm-09-01698/article_deploy/html/images/jcm-09-01698-g001.png)